Overreaction I think many here would make great executives and would do great investor relations work. Unfortunately as a shareholder, you've allocated that responsibility to the company. You can vote your shares and even become an activist if you have enough shares. As a shareholder you are not entitled to the whole story, in fact you are only entitled to public information. If you get non public information you are locked out from trading the stock. As much as I would like a prefect message from the company, I would prefer them to execute in getting another drug approved with the FDA, which they have been successful at before. So either trust them and keep your shares or don't and sell them - but to bombard them for not being perfect in answering questions around non public information isn't fair. They have improved communication extremely well since the end of last year and are allocating resources to improving in that arena, that part is clear to me. Also, today's addition of the Molson family is likely the largest endorsement in credibility one could ask for, but I'm sure it's not good enough to those on this board that are short term focused on next weeks share price..., patience folks!!